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Abstract
Background: Most patients who suffer a stroke experience reduced walking competency and health-related quality of
life (HRQoL). A key factor in effective stroke rehabilitation is intensive, task-specific training. Recent studies suggest that
intensive, patient-tailored training can be organized as a circuit with a series of task-oriented workstations.
Primary aim of the FIT-Stroke trial is to evaluate the effects and cost-effectiveness of a structured, progressive task-
oriented circuit class training (CCT) programme, compared to usual physiotherapeutic care during outpatient
rehabilitation in a rehabilitation centre. The task-oriented CCT will be applied in groups of 4 to 6 patients. Outcome will
be defined in terms of gait and gait-related ADLs after stroke. The trial will also investigate the generalizability of
treatment effects of task-oriented CCT in terms of perceived fatigue, anxiety, depression and perceived HRQoL.
Methods/design: The multicentre single-blinded randomized trial will include 220 stroke patients discharged to the
community from inpatient rehabilitation, who are able to communicate and walk at least 10 m without physical, hands-
on assistance. After discharge from inpatient rehabilitation, patients in the experimental group will receive task-oriented
CCT two times a week for 12 weeks at the physiotherapy department of the rehabilitation centre. Control group
patients will receive usual individual, face-to-face, physiotherapy. Costs will be evaluated by having each patient keep a
cost diary for the first 24 weeks after randomisation. Primary outcomes are the mobility part of the Stroke Impact Scale
(SIS-3.0) and the EuroQol. Secondary outcomes are the other domains of SIS-3.0, lower limb muscle strength, walking
endurance, gait speed, balance, confidence not to fall, instrumental ADL, fatigue, anxiety, depression and HRQoL.
Discussion: Based on assumptions about the effect of intensity of practice and specificity of treatment effects, FIT-
Stroke will address two key aims. The first aim is to investigate the effects of task-oriented CCT on walking competency
and HRQoL compared to usual face-to-face physiotherapy. The second aim is to reveal the cost-effectiveness of task-
oriented CCT in the first 6 months post stroke. Both aims were recently recommended as priorities by the American
Hearth Association and Stroke Council.
Trial registration: This study is registered in the Dutch Trial Register as NTR1534.
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Background
The number of stroke patients is rising worldwide. The
number in The Netherlands has been estimated at 7.5 per
1000, resulting in a prevalence of 118,500 in the year
2000[1]. Costs related to the care of stroke patients are
extremely high and estimated to exceed one billion Euros
in The Netherlands alone[2]. These numbers are expected
to increase by 27% in 2020, due to improved health care
and the ageing population[1].
Stroke patients experience lifetime disabilities and need
care over a long period of time to cope with the conse-
quences of their stroke. One study found that after reha-
bilitation, 62% of stroke patients were still dependent
regarding daily living activities (ADL) and 32% were inac-
tive regarding Instrumental ADLs at three years post
stroke[3]. Moreover, about one fifth of chronic stroke
patients suffer a significant decline in mobility[4],
whereas less than 50% of patients manage to walk inde-
pendently in the community again[5,6]. A qualitative
study showed that loss of independent ambulation, espe-
cially outdoors, was one of the most disabling aspects for
stroke patients[7]. Mobility-impaired patients are prone
to inactivity and often have a sedentary lifestyle, which
may result in a variety of problems including deteriorating
gait, social isolation, feelings of depression and fatigue,
ultimately affecting their quality of life[4]. In addition,
reduced exercise tolerance as a result of inactivity may lead
to secondary complications in stroke survivors, such as
reduced cardio-respiratory fitness, muscle atrophy, oste-
oporosis and impaired circulation in the lower extremi-
ties[8]. Moreover, many patients with stroke suffer from
diabetes mellitus, high blood pressure, body mass index
above 30 and coronary heart disease, factors that in them-
selves increase the risk of other cardiovascular events,
including recurrent strokes [9-11]. The lack of walking
competency and physical fitness after stroke due to inac-
tivity is of great concern to the health care system, as it is
presumably associated with increasing costs[8].
A number of studies have shown that walking competency
can be improved when practice is delivered in an inten-
sive, and preferably task-oriented way [12-19]. For exam-
ple, a meta-analysis of 13 RCTs (N = 501) showed that
rehabilitation services in which the physical training is
applied in a progressive and preferably task-oriented way
are more effective than usual individual care, in terms of
gait speed and walking distance[18]. Unfortunately, most
stroke physiotherapists and occupational therapists are
hampered in the implementation of intensive, task-ori-
ented training by lack of time due to insufficient staff and
inefficient use of human resources[20,21]. Group train-
ing, in which multiple patients practice meaningful tasks
simultaneously, may be an effective method to overcome
this problem. A recent meta-analysis showed that task-ori-
ented circuit class training (CCT), in which training is
organized as a circuit with a series of workstations, had
positive effects in terms of gait speed, walking distance
and the timed-get-up and go test, compared to usual
care[19].
Task-oriented CCT generally seems to satisfy at least three
key conditions for an effective and efficient physical train-
ing programme compared to usual face-to-face training.
First, the use of different workstations in task-oriented
CCT allows patients to practice intensively in a meaning-
ful and progressive scheme suited to their individual
needs. Second, task-oriented CCT might represent an effi-
cient use of therapists' time while patients actively engage
in task practice, compared to individual therapy. This
makes circuit class training a potentially effective method
which saves costs to the health care system by reducing
staff-to-patient ratios. Third, task-oriented CCT involves
group dynamics including peer support and social interac-
tion[22].
Unfortunately, the literature offers only a few high-quality
studies on the effectiveness of task-oriented CCT, whereas
studies investigating its cost-effectiveness are still lack-
ing[14,17,19]. The American Hearth Association recently
emphasized the need for research to explore the health
benefits and cost-effectiveness of structured exercise pro-
grammes to improve physical fitness in patients with
stroke[8].
The study whose protocol is presented here intends to
investigate the effectiveness and cost-effectiveness of task-
oriented CCT programmes compared to usual face-to-face
physiotherapy provided during outpatient physiotherapy
treatment at a rehabilitation centre. We hypothesize that
task-oriented CCT programmes will be a better strategy to
improve functional outcome in patients discharged to the
community from a rehabilitation centre than individual
face-to-face training at the physiotherapy department of
an outpatient rehabilitation clinic. In addition, based on
the rules for reimbursement by insurance companies, we
assume that training in groups will entail lower short-term
and long-term costs to the health care system than face-to-
face treatments applied individually by a physiotherapist.
Methods/design
Design
The effects of the task-oriented CCT programme will be
investigated by means of a stratified, multicentre, single-
blinded, randomized controlled trial (RCT) conducted by
specially trained staff in nine selected rehabilitation cen-
tres in The Netherlands. Within each participating rehabil-
itation centre, patients will be allocated to the task-
oriented CCT (experimental group) or regular face-to-faceBMC Neurology 2009, 9:43 http://www.biomedcentral.com/1471-2377/9/43
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physiotherapy (control group) for outpatient rehabilita-
tion.
Setting
The study will be conducted in nine rehabilitation centres
in The Netherlands ('De Hoogstraat', Utrecht; 'Heli-
omare', Wijk aan Zee; 'Rijnlands Revalidatiecentrum', Lei-
den; 'Sophia Revalidatie', Den Haag; 'Stichting Revalidatie
Breda', Breda; 'Via Reva/Kastanjehof', Apeldoorn; 'Roess-
ingh', Enschede; 'De Trappenberg', Huizen and 'Vogel-
landen', Zwolle). All patients will complete an inpatient
rehabilitation period and will be included when they start
their outpatient rehabilitation period.
Participants
Eligible subjects will have to meet the following inclusion
criteria: (1) verified stroke according to the WHO defini-
tion[23], (2) ability to walk a minimum of 10 m without
physical assistance from a therapist. (i.e., patient may
require verbal supervision or stand-by help from a person,
and using an aid or orthotics is allowed) (Functional
Ambulation Categories ≥ 3); (3) discharged home from a
rehabilitation centre; (4) need to continue physiotherapy
during outpatient care to improve walking competency
and/or physical condition; (5) giving informed consent
and being motivated to participate in 24 fitness training
sessions over a 12-week period, or in usual care. Patients
will be excluded if they (1) suffer from severe cognitive
deficits as evaluated by the Mini-Mental State Examina-
tion (<24 points); (2) are unable to communicate (i.e. < 4
points on the Utrechts Communicatie Onderzoek) or (3)
live more than 30 km from the rehabilitation centre.
Before discharge from an inpatient rehabilitation setting,
patients will be recruited by their own physician, and after
they have given written informed consent, an observer
will verify if all inclusion criteria have been met to partic-
ipate in the trial. The FIT-Stroke protocol has been
approved by the Medical Ethics Committee of the Univer-
sity Medical Centre Utrecht and all the participating reha-
bilitation centres. The trial is registered in the Dutch Trial
Register (NTR1534).
Definitions used in FIT-Stroke
Task-oriented circuit class training is defined in the present
study as therapy provided to at least 2 participants simul-
taneously, which involves a series of workstations focus-
ing on gait practice and functional gait-related tasks. The
workstations are organized as a circuit, and the exercise at
each workstation has to be progressive, i.e., increasing the
number of repetitions completed at a workstation and/or
increasing the complexity of the exercise performed at
each station[19]. Circuit class training allows staff-to-
patient ratios to be lower than they are in individual phys-
iotherapy and enables a group of patients to exercise at
different workstations simultaneously under the supervi-
sion of one or more therapists[24].
Walking competence is defined as 'the ability to perform
gait and gait-related tasks successfully', with gait-related
activities defined as activities involving mobility-related
tasks such as stair walking, turning, making transfers,
walking quickly and walking specified distances'[18].
Independent gait is defined as level three or higher accord-
ing to the Functional Ambulation Categories (FAC). FAC
3 reflects that patients require verbal supervision or stand-
by-help from one person without physical contact,
whereas FAC 4 indicates that patients are safe walkers on
level ground, but require help on stairs, slopes or uneven
surfaces, and FAC 5 means that patients are able to walk
independently anywhere[25,26].
The proposed study will determine cost-effectiveness  by
relating the costs to the effects of the programme. The
effects will be expressed as quality-adjusted life years
(QALYs) determined by the EQ5D. The costs include the
costs related to resource use of primary care practitioners,
secondary care appointments, admissions to health care
facilities, community-based support and individual out-
of-pocket expenditure (direct costs). Medication costs and
costs related to devices and adaptations in and around the
house will also be included. The costs of productivity
losses (indirect costs) will not be included in the analysis.
The incremental cost-effectiveness ratio (ICER) will be
determined by dividing the mean difference in costs by
the mean difference in effect between the two groups.
Procedure
Patients will be stratified by rehabilitation centre and sub-
sequently randomized to task-oriented CCT or to individ-
ual face-to-face physiotherapy, using an 'online'
minimization procedure[27]. The intervention period
will be 12 weeks and measurements will be taken at base-
line, 6, 12, 18 and 24 weeks. All outcomes measured at
baseline, 12 and 24 weeks will be assessed in face-to-face
meetings by an independent researcher, blinded for treat-
ment allocation, whereas at 6 and 18 weeks, a restricted
set from the test battery will be assessed by semi-struc-
tured telephone interviews (Figure 1).
Intervention group
Patients assigned to the intervention group (two partici-
pants or more) will receive a 90-minute structured pro-
gressive task-oriented CCT programme twice a week over
a twelve-week period (24 sessions). The programme
includes 4 stages: (1) warming up (5 minutes), (2) circuit
class training (60 minutes), (3) evaluation and a short
break (10 minutes) and (4) group game (15 minutes).
The training programme includes 8 different worksta-
tions, intended to improve meaningful tasks related toBMC Neurology 2009, 9:43 http://www.biomedcentral.com/1471-2377/9/43
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walking competency, such as balance control, stair walk-
ing, turning, transfers and speed walking. The eight work-
stations incorporated in the circuit are: (1) standing and
reaching; (2) stair walking including transfer; (3) walking
and picking up various objects from the ground; (4) kick-
ing a ball; (5) stepping up and down; (6) walking course
with obstacles; (7) transfers (lying to standing and sit-
ting); and (8) speed walking. Graded progression will be
achieved by (1) increasing the difficulty of the task; (2)
adding weights; or (3) increasing the number of repeti-
tions. No special (fitness) equipment is needed to per-
form the tasks. Each workstation will be done for 3
minutes, followed by 3 minutes of rest and 1 minute to
change to the next workstation. The participants will com-
plete the exercises in pairs, where one does the exercise
while the 'partner' has a rest period and helps the other by
keeping track of the number of repetitions and stimulates
him/her to perform at their best. Time will be kept by the
supervisors. The precise composition of the treatment
package for each patient, in terms of appropriate selection
of type of workstation, number of repetitions and inten-
sity, will be determined at baseline, based on patients'
profiles in terms of muscle strength, physical fitness and
mobility status. All patients will keep an activity log in
which they record the number of repetitions at each work-
station during the sessions, which they will then use as
feedback in the next session. The one-hour session of
workstation training will be followed by a 15-minute
group game, in which the whole group performs a game
to improve walking competency. Games will vary across
the sessions. Options include a game in which walking
tasks are combined with a cognitive task, or a game con-
sisting of fast walking and changing directions. Ball games
can of course be used as well, as long as they serve to train
walking performance. Incidents that occur during the
training sessions (e.g. falls) will be reported by the super-
visors to the independent investigator and registered in a
falls diary. Patients who are allocated to the intervention
group will receive no other physiotherapeutic treatment
for the lower extremities.
Control group
Patients who are allocated to the control group will
receive regular care and will therefore be referred to the
usual outpatient face-to-face treatment given by physio-
therapists at the rehabilitation centres. Treatment
designed to improve standing balance control, physical
condition and gait performance will be provided. No
additional restrictions will be imposed with respect to
content, time or duration of the therapy.
Compliance
In order to conduct this trial uniformly in nine different
rehabilitation centres, all supervisors have to be trained in
a one-day course before the FIT-Stroke trial starts. In the
past year, about 60 physiotherapist and sports therapists
have been trained. Each therapist has been informed
about: (1) the criteria for recruitment of candidates dis-
charged from the inpatient rehabilitation centre; (2) the
aims, design and measurement instruments of the FIT-
stroke trial, (3) how to fill in the patients' training diaries,
(4) the focus and content of the task-oriented CCT pro-
gramme and (5) how to stimulate the participants to
maintain an active lifestyle after the task-oriented CCT
sessions end. After practical training about applying and
adapting the eight workstations and how to intensify the
Flow chart Figure 1
Flow chart.
R
intervention
control baseline
1
sustainability
2 4 3 5
R= Randomization in permuted blocks within each participating rehabilitation centre:
1. Measurement 1 baseline, start of intervention at discharge from rehabilitation centre
2. Measurement 2 (restricted assessments at 6 weeks post randomization)  
3. Measurement 3 end of intervention phases (12 weeks post randomization)  
4. Measurement 4 (restricted assessments at 18 weeks post randomization)
5. Measurement at short-term follow-up (24 weeks post randomization)BMC Neurology 2009, 9:43 http://www.biomedcentral.com/1471-2377/9/43
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workload progressively, all trained supervisors were able
to conduct the intervention in a standardized manner.
Subsequently, all other physiotherapists, sports therapists
and physicians who will be involved in the treatment of
the included stroke patients were informed about the con-
tent of the intervention by means of presentations in each
rehabilitation centre. In order to prevent contamination,
therapists were instructed not to change the treatment
procedures of the usual face-to-face physiotherapy during
the trial. Finally, all managers of rehabilitation centres
were asked not to change treatment policies during the
FIT-Stroke trial. In the coming years, retraining activities
will be organized and an independent investigator (IvdP)
will monitor on a regular basis whether the content of the
task-oriented CCT and the usual physiotherapy are being
implemented as intended in the nine rehabilitation cen-
tres.
Outcome measures
The following descriptive variables will be used for the
FIT-Stroke Trial: (1) Utrechts Communicatie Onderzoek
(UCO). The UCO assesses patients' ability to communi-
cate on a five-point Likert scale, ranging from 'not able to
communicate' to 'no communication problems'[28]. (2)
Cumulative Illness Rating Scale (CIRS). Co-morbidity will
be assessed by the CIRS, which is a valid and reliable
instrument that addresses all relevant body systems with-
out using specific diagnoses[29]. (3) Mini Mental State
Examination (MMSE). Cognitive functioning will be
determined by the MMSE[30]. A score lower than 24
points indicates the presence of cognitive problems[31].
The effect of the intervention will be measured at different
outcome levels to determine effectiveness and cost-effec-
tiveness. Primary outcome measure will be the mobility
domain of the Stroke Impact Scale (SIS, version 3.0) and
the EuroQoL.
Stroke Impact Scale (SIS) version 3, Mobility domain
The SIS is a self-reported, stroke-specific measure that
includes 59 items and assesses 8 domains related to activ-
ities and participation[32]. The mobility domain of the
SIS includes 9 questions about patients' perceived compe-
tency to keep their balance, to transfer, to walk indoors
and climb stairs, to get in and out of a car and to move in
their own community. Each item is scored from 'not diffi-
cult at all' to 'cannot do it at all' on a 5-point scale. A dif-
ference of 10 points on the 'mobility at home and in the
community' domain of the SIS is regarded as clinically rel-
evant[33]. SIS has shown excellent clinimetric properties
in terms of concurrent and construct validity, test-retest
reliability and responsiveness[33,34]. Proxies can also
provide valid information on SIS outcome[34]. The SIS
has recently been translated into Dutch and the Dutch ver-
sion showed similar clinimetric properties when re-tested
in 27 stroke patients[35]. The SIS will be applied at base-
line and 6, 12, 18 and 24 weeks after randomization.
EuroQoL
The EuroQol is a generic measure of quality of life (QoL)
and consists of a health status profile in five domains (EQ-
5D), including two that are directly related to mobil-
ity[36]. It also includes a visual analogue scale (VAS)
reflecting patients' overall judgement about their current
health status. The EuroQol has been validated for use in
stroke[37,38]. The advantage of the EuroQol is that it can
be transformed into a utility score based on patients' VAS
scores and population estimates of the health-status pro-
file, allowing cost-effectiveness assessment. The VAS score
will be used to detect possible overall effects of the train-
ing programme, compared to usual care, that were not
specifically targeted by the intervention programme. For
short-term effects, the EuroQol will be assessed at baseline
and 6, 12, 18 and 24 weeks after randomization.
Secondary outcome measures are the following
Stroke Impact Scale (SIS) version 3.0, other domains
The other 7 domains of the SIS 3.0 will be assessed as sec-
ondary outcome measures at baseline and 6, 12, 18 and
24 weeks after randomization
Motricity Index (MI)
The MI is a valid and reliable measure[39] and will be
used to determine the strength of the upper (MI arm) and
lower paretic limb (MI leg). Scores range from 0 (no activ-
ity) to 33 (maximum muscle force) for each dimension.
The test has proved highly reliable and valid[39]. The MI
will be assessed at baseline and 12 and 24 weeks post ran-
domization.
Functional Ambulation Categories (FAC)
Walking ability will be determined using the FAC. It
includes six categories with scores ranging from 0 to 5, viz.
from unable to walk to independently walking without
physical assistance[26,40], though only patients with FAC
3 or higher will be recruited for the FIT-stroke trial. The
test will be applied at baseline and 12 and 24 weeks post
randomization.
Six-minute walking test
The effects of functional fitness training on gait perform-
ance and endurance will be assessed by the 6-minute
walking test (6-MWT)[41]. The test will be applied at
baseline and 12 and 24 weeks post randomization.
Five-metre timed walk
Gait speed will be measured by the 5 meter comfortable
walking speed test. Gait speed is responsive to change and
closely related to walking performance in hemiplegicBMC Neurology 2009, 9:43 http://www.biomedcentral.com/1471-2377/9/43
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patients[40]. In order to reduce measurement error, the
mean of three repeated walking speed measurements will
be calculated[25]. Patients will rest for about one minute
between each test. Using a digital stopwatch that records
time within 0.01 second, timing will be manually started
at the 'go' instruction and stopped when the subject
crosses the 5 meter mark. The test will be applied at base-
line and 12 and 24 weeks post randomization.
Timed balance test (TBT)
The TBT consists of 5 different components on an ordinal
scale and involves timed balance (i.e., 60 seconds) on pro-
gressively diminishing support surfaces. The test has been
shown to be reliable and closely related to walking per-
formance[40,42]. The test will be used at baseline and 12
and 24 weeks post randomization.
Timed up and go test (TUG)
The TUG is a test of basic functional mobility. The partic-
ipant is asked to rise from an armchair, walk 3 m as fast as
possible, cross a line, turn, walk back and sit down again.
The time taken to perform this task is recorded. The TUG
has been shown to identify patients at increased risk of
falls[43]. The test will be applied at baseline and 12 and
24 weeks post randomization.
Modified stairs test
The modified stairs test is an extended version of the
Timed up and go test (TUG). The test includes the same
tasks as the TUG, plus ascending and descending 5
steps[44]. Patients are timed to the nearest 0.01 s from the
moment they are asked to rise from a chair which is placed
0.5 meters in front of the stairs, ascend 5 steps, turn and
descend the 5 steps and sit down again in the chair as
safely as possible. Patients rest for about one minute
between each test. The test will be applied at baseline and
12 and 24 weeks post randomization.
Rivermead Mobility Index (RMI)
The RMI consists of 14 questions and one observation,
covering aspects ranging from turning in bed to run-
ning[45]. Questions are simple and are scored dichoto-
mously. The measure is reliable, valid and responsive [45-
47]. The RMI will be applied at baseline, 12 and 24 weeks
post randomization.
Nottingham Extended ADL (NEADL)
The NEADL scale[48] is based on a self-reported question-
naire on levels of activity actually performed. The NEADL
consists of 22 items in 4 domains (mobility, kitchen,
domestic, leisure). The NEADL is specifically designed for
postal use with stroke patients, and has proved to be reli-
able and valid as an outcome measure in trials and obser-
vational studies. Each item is rated by one of four
responses (able, able with difficulty, able with help, una-
ble). The scale has been shown to have reasonable hierar-
chical (ordinal) properties in stroke patients. The NEADL
will be assessed at baseline and 12 and 24 weeks post ran-
domization.
All of the above tests, for both the experimental and con-
trol groups, will be implemented at the participants' own
home by an independent observer who is blinded to treat-
ment allocation.
Falls Efficacy Scale (FES)
The FES is an instrument to measure fear of falling, based
on the operational definition of this fear as 'low perceived
self-efficacy at avoiding falls during essential, nonhazard-
ous activities of daily living'[49]. The FES will be assessed
at baseline and 12 and 24 weeks post randomization.
Hospital Anxiety and Depression Scale (HADS)
The HADS is a simple measure to determine mood, emo-
tional distress, anxiety, depression and emotional disor-
der. It is a brief, valid, reliable and widely used measure,
known to produce meaningful results as a psychological
screening tool. The HADS consists of 14 items (7 anxiety,
7 depression), each with a 4-point rating scale (0–3) and
has proved to be responsive to change[50,51]. The HADS
will be assessed at baseline and 12 and 24 weeks after ran-
domization.
Fatigue Severity Scale (FSS)
The FSS will be used to assess the impact of fatigue. The
FSS consists of 9 items, and scores for each item range
from 1 to 7. The total FSS score is the mean of the 9 item
scores[52]. In a reliability study with two independent
observers and 18 stroke patients, FSS showed an intra-
class correlation coefficient (ICC) of 0.82[53]. The FSS
will be applied at baseline and 12 and 24 weeks post ran-
domization.
Letter cancellation task
Inattention will be measured by the letter cancellation
task[54] and will be scored positive when patients score
three omissions or more on one side, compared to the
other side.
Diaries
Finally, each patient will be asked to keep a cost diary,
which will be used to assess medical consumption in both
arms of the study. Patients will be asked to record their
medical consumption (for example visits to a general
practitioner, hospital visits, medication intake) each
week. In addition, they will be asked to record their level
of activities during the day (activity log) as well as special
events (e.g. falls). This dairy will be kept daily for 12
weeks. After 12 weeks, the patients will be asked to con-
tinue recording weekly until 24 weeks after inclusion.BMC Neurology 2009, 9:43 http://www.biomedcentral.com/1471-2377/9/43
Page 7 of 9
(page number not for citation purposes)
Power analysis
A difference of 5 points (about 11%) on the 'mobility at
home and in the community' domain of the SIS in favour
of the experimental group will be regarded as clinically
relevant[33], whereas the standard deviation for this pop-
ulation is estimated at a maximum of 14 points (28%)
based on 287 mild and moderate SIS responses[55]. In
addition, test-retest reliability (ICC) is known to be about
0.8[33], whereas the FIT-Stroke trial uses 4 repeated meas-
urements in the first 24 weeks after randomization. There-
fore, a minimum of 99 patients will be required for each
arm of the trial. Expecting a dropout rate of 10%, we
assume that a minimum of 220 stroke patients will be
needed to achieve a sufficient statistical power of 80%.
Data analysis
The present trial, with repeated measurements nested in
each patient, will apply a random coefficients model
(MLWIN, version 2.11) to evaluate differences in effect
between the experimental and control intervention arms.
Besides the type of intervention, the model will include
significant factors such as covariates, which will be estab-
lished by means of (univariate) regression analysis. It
should be noted that Random Coefficient Analysis (RCA)
is able to deal with (partially) or completely missing val-
ues and enables an 'intention-to-treat' analysis. Economic
evaluation will be conducted from the main assumption
underlying the present study, that the proposed fitness
training programme, which allows stroke patients to train
in groups of 8 to 10, will result in a better walking compe-
tency as well as improved (I)ADL and HRQoL, with net
savings on resources (i.e., costs), compared to the control
intervention. The balance between costs and effects will
be estimated, in accordance with the Dutch guidelines for
pharmaco-economic research, by means of multivariable
probabilistic data analysis [56]. The cost diary will com-
prise detailed questions on items such as consultations
with neurologists, family doctors, paramedics, home care
and non-professional support, and the answers will be
used in the costs evaluation. Provision of medication by
pharmacies in the community will also be recorded to
keep track of expenses related to drug use. The diary will
also record low volumes of high-cost resources, such as re-
admission to hospitals and rehabilitation centres. Ulti-
mately, multiplication of resource use and unit costs,
which will be determined in a separate cost study, will
yield an estimate of patient-level cost. Subsequently, sum-
mation across individual patient records and averaging
will yield an estimate of total costs per intervention arm.
In addition, the impact of task-oriented CCT in terms of
health-related quality of life will be determined using the
EuroQol 5D (EQ-5D). The EQ-5D is a 5-item question-
naire that can be converted into a single value score (i.e.,
utility) for HRQoL, yielding an estimate of the quality-
adjusted survival time (QALYs). This estimate will serve as
the primary measure of effectiveness for the economic
evaluation.
Discussion
The FIT-Stroke trial is a single-blinded multicentre trial in
which 220 patients will be allocated to task-oriented CCT
or usual face-to-face treatment at the nine participating
rehabilitation centres, on the basis of a minimization pro-
cedure. The minimization procedure used for patient allo-
cation has been recommended as a highly effective
allocation method for randomized controlled trials[27].
The main characteristics of the task-oriented CCT pro-
gramme are the progressive intensity and task specificity
of the workstations used. The eight different functional
workstations used in the trial have been found to be
meaningful and relevant to patients' needs, goal-oriented,
challenging, and feasible (i.e., not to easy and not to diffi-
cult). As such, the programme builds heavily on the exist-
ing evidence that intensity of practice[12,57] as well as
task specificity[13,57] are the main drivers of gait
improvement. After reviewing 14 trials, French and col-
leagues[13] showed that repetitive task-oriented training
resulted in modest improvement in lower limb function.
Although the authors claimed that the repetitive lower
limb training was sufficient to influence daily living func-
tions, no evidence was found that the effects of repetitive
training were sustained once training had ended. In order
to fill this gap in existing evidence, the FIT-Stroke trial will
have a follow-up of three months to investigate the possi-
ble wash-out effects of the task-oriented CCT programme.
Recently, Wevers and colleagues showed significant effects
in favour of task-oriented CCT for walking distance, gait
speed and a timed up-and-go test in their systematic
review of randomized controlled trials including 307 par-
ticipants[19]. The intensity of task-oriented CCT ranged
from 4 weeks (3 times a week for 60 minutes)[24] to 19
weeks (3 times a week for 60 minutes)[58]. Therefore, we
assume that in the present study, a training schedule of 24
sessions each lasting 90 minutes within 12 weeks will be
sufficient to achieve functional gains in gait and gait-
related activities. Unfortunately, most studies included in
the above meta-analysis were small and statistically
underpowered, ranging from 12[24] to 91[59] partici-
pants, which suggests that larger trials are warranted. Only
one study[60] included in the meta-analysis investigated
the effects of task-oriented CCT within the first 6 months
post stroke. Interestingly, this study found a larger effect
size than those that investigated effects in chronic stroke.
However, none of the included studies compared the cost-
effectiveness of task-oriented CCT with that of usual care,
which is particularly important in view of the burden of
health care costs for stroke and attempts to save costs in
stroke management. This aim is in line with the views ofBMC Neurology 2009, 9:43 http://www.biomedcentral.com/1471-2377/9/43
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the American Hearth Association (AHA), which recently
recommended that fundraisers and researchers should
conduct cost-effectiveness studies in the growing and age-
ing stroke population[8]. By including 220 patients
within the first months after their stroke and focusing on
cost-effectiveness as well as health-related quality of life,
we hope to fill the existing gaps in stroke rehabilitation
research.
Finally, we will give special attention to the generalizabil-
ity of the effects of this physical intervention to psycho-
social outcomes, like fatigue, anxiety and depressive
symptoms. Including a large population will enable us to
conduct sub-analyses on smaller groups for these less fre-
quent outcomes. The larger population will also enable us
to record the effects on other less frequent outcomes like
recurrent stroke, and co-morbidities like cardiac prob-
lems. Ongoing participation in physical activity may also
reduce the prevalence of vascular risk factors and so
reduce the risk of coronary heart diseases and recurrent
strokes[10,11]. For example, a meta-analysis[61] has
demonstrated that increased physical activity improves
cardiac performance and exercise capacity in patients with
heart failure.
In conclusion, task-orientated CCT holds great potential
for the rehabilitation of people after stroke, allowing the
training schedule to be customized to the individual sta-
tus of each participant. We hypothesize that task-oriented
CCT will be equally effective in improving gait and gait-
related activities in stroke as face-to-face therapy alone, or
even more so. The FIT- Stroke trial will give us a unique
opportunity to study the effects of task-oriented circuit
class training in a large and carefully designed trial. The
first results of the study are expected in August 2011.
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